Publications dans lesquelles il/elle collabore avec José Alberto Orfao de Matos Correia e Vale (30)

2022

  1. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

    Blood, Vol. 140, Núm. 1, pp. 38-44

2021

  1. Dynamic Intracellular Metabolic Cell Signaling Profiles During Ag-Dependent B-Cell Differentiation

    Frontiers in Immunology, Vol. 12

2020

  1. Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube

    Frontiers in Immunology, Vol. 11

  2. STAT3 and STAT5B mutations in T/NK-cell chronic lymphoproliferative disorders of large granular lymphocytes (LGL): Association with disease features

    Cancers, Vol. 12, Núm. 12, pp. 1-20

2019

  1. Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis

    Cell Death Discovery, Vol. 5, Núm. 1

2018

  1. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy

    Modern Pathology, Vol. 31, Núm. 8, pp. 1318-1331

  2. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome

    Haematologica, Vol. 103, Núm. 7, pp. 1198-1208

2017

  1. Maturation-associated gene expression profiles along normal human bone marrow monopoiesis

    British Journal of Haematology, Vol. 176, Núm. 3, pp. 464-474

2016

  1. Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: A new model to understand chemoresistance

    Blood, Vol. 127, Núm. 15, pp. 1896-1906

2015

  1. Ex vivo identification and characterization of a population of CD13high CD105+ CD45- mesenchymal stem cells in human bone marrow

    Stem Cell Research and Therapy, Vol. 6, Núm. 1

  2. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

    Leukemia, Vol. 29, Núm. 5, pp. 1186-1194

  3. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: A surrogate marker for NK-cell clonality

    Oncotarget, Vol. 6, Núm. 40, pp. 42938-42951

  4. The cellular origin and malignant transformation of Waldenström macroglobulinemia

    Blood, Vol. 125, Núm. 15, pp. 2370-2380

2014

  1. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance

    Haematologica, Vol. 99, Núm. 1, pp. 155-162

  2. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

    Leukemia

  3. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene

    American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294

2013

  1. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: A study in highly purified aberrant plasma cells

    Haematologica, Vol. 98, Núm. 2, pp. 279-287

  2. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

    Blood, Vol. 122, Núm. 22, pp. 3591-3598

  3. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

    Journal of Allergy and Clinical Immunology, Vol. 131, Núm. 4

2012

  1. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas

    American Journal of Pathology, Vol. 181, Núm. 5, pp. 1749-1761